PubMed

Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.

Zhang J, Gerhardinger C, Lorenzi M.

Diabetes. 2002 Dec;51(12):3499-504.PMID: 12453906 [PubMed - indexed for MEDLINE]Related articlesFree article

Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy.

Gerl VB, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S.

Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1104-8.PMID: 11923252 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.

Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu GT.

Invest Ophthalmol Vis Sci. 2008 Feb;49(2):732-42.PMID: 18235022 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells.

Accardo-Palumbo A, Triolo G, Colonna-Romano G, Potestio M, Carbone M, Ferrante A, Giardina E, Caimi G, Triolo G.

Diabetologia. 2000 Aug;43(8):1039-47.PMID: 10990082 [PubMed - indexed for MEDLINE]Related articles

Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.

Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M.

Diabetes. 2004 Sep;53(9):2404-11.PMID: 15331552 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased prevalence of microthromboses in retinal capillaries of diabetic individuals.

Boeri D, Maiello M, Lorenzi M.

Diabetes. 2001 Jun;50(6):1432-9.PMID: 11375345 [PubMed - indexed for MEDLINE]Related articlesFree article

Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.

Miwa T, Zhou L, Hilliard B, Molina H, Song WC.

Blood. 2002 May 15;99(10):3707-16.PMID: 11986227 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular wall von Willebrand factor in human diabetic retinopathy.

Boeri D, Cagliero E, Podestá F, Lorenzi M.

Invest Ophthalmol Vis Sci. 1994 Feb;35(2):600-7.PMID: 8113010 [PubMed - indexed for MEDLINE]Related articlesFree article

Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis.

Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P.

Am J Pathol. 2000 Sep;157(3):905-18.PMID: 10980130 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT.

Am J Pathol. 2008 May;172(5):1411-8. Epub 2008 Apr 10.PMID: 18403591 [PubMed - indexed for MEDLINE]Related articlesFree article

Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.

Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP.

Diabetes. 2007 Feb;56(2):373-9.PMID: 17259381 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation.

Devaux P, Christiansen D, Fontaine M, Gerlier D.

Eur J Immunol. 1999 Mar;29(3):815-22.PMID: 10092084 [PubMed - indexed for MEDLINE]Related articles

Captopril inhibits glucose accumulation in retinal cells in diabetes.

Zhang JZ, Gao L, Widness M, Xi X, Kern TS.

Invest Ophthalmol Vis Sci. 2003 Sep;44(9):4001-5.PMID: 12939321 [PubMed - indexed for MEDLINE]Related articlesFree article

Blood-retinal barrier breakdown induced by activation of protein kinase C via vascular endothelial growth factor in streptozotocin-induced diabetic rats.

Xu X, Zhu Q, Xia X, Zhang S, Gu Q, Luo D.

Curr Eye Res. 2004 Apr;28(4):251-6.PMID: 15259294 [PubMed - indexed for MEDLINE]Related articles

VEGF164 is proinflammatory in the diabetic retina.

Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, Amano S, Hida T, Oguchi Y, Adamis AP.

Invest Ophthalmol Vis Sci. 2003 May;44(5):2155-62.PMID: 12714656 [PubMed - indexed for MEDLINE]Related articlesFree article

Enhancement of P2X(7)-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature.

Sugiyama T, Kobayashi M, Kawamura H, Li Q, Puro DG.

Invest Ophthalmol Vis Sci. 2004 Mar;45(3):1026-32. Erratum in: Invest Ophthalmol Vis Sci. 2004 May;45(5):1296]. Kobayshi, Masato [corrected to Kobayashi, Masato]. PMID: 14985326 [PubMed - indexed for MEDLINE]Related articlesFree article

Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.

Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV.

Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5257-65.PMID: 17962481 [PubMed - indexed for MEDLINE]Related articlesFree article

C-peptide and retinal microangiopathy in diabetes.

Chakrabarti S, Khan ZA, Cukiernik M, Zhang W, Sima AA.

Exp Diabesity Res. 2004 Jan-Mar;5(1):91-6. Review.PMID: 15198374 [PubMed - indexed for MEDLINE]Related articlesFree article

Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation.

Triolo G, Accardo-Palumbo A, Sallì L, Ciccia F, Ferrante A, Tedesco L, Sallì S, Giardina E, Pappalardo A, Licata G.

Clin Exp Rheumatol. 2003 Mar-Apr;21(2):225-8.PMID: 12747280 [PubMed - indexed for MEDLINE]Related articles

Role of endothelin in diabetic retinopathy.

Lam HC, Lee JK, Lu CC, Chu CH, Chuang MJ, Wang MC.

Curr Vasc Pharmacol. 2003 Oct;1(3):243-50. Review.PMID: 15320471 [PubMed - indexed for MEDLINE]Related articles